Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Q2 2023 vs. Q1 2023
How the institutions holding Wave Life Sciences, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 73 | 81 | +8 |
| Shares | 70.1M | 72.2M | +2.11M (+3.0%) |
| Value | $303.5M | $262.7M | −$40.8M (−13.4%) |
New holders (26)
Institutions that held Wave Life Sciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (18)
Institutions that held Wave Life Sciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Woodline Partners LP | 510,898 | $2.21M |
| Jane Street Group, LLC | 372,481 | $1.61M |
| HRT Financial LP | 233,278 | $1.01M |
| Qube Research & Technologies Ltd | 168,624 | $730.1K |
| Cubist Systematic Strategies, LLC | 71,489 | $309.5K |
| Verition Fund Management LLC | 54,841 | $237.5K |
| LMR Partners LLP | 39,459 | $170.9K |
| Man Group plc | – | $143.3K |
| Balyasny Asset Management LLC | 30,154 | $130.6K |
| Diametric Capital, LP | 25,011 | $108.3K |
| Boothbay Fund Management, LLC | 23,166 | $100.3K |
| Y-Intercept (Hong Kong) Ltd | 21,667 | $93.8K |
| Point72 Asset Management, L.P. | 15,800 | $68.4K |
| Point72 Middle East FZE | 12,601 | $54.6K |
| Jefferies Financial Group Inc. | 11,801 | $51.1K |
| Schonfeld Strategic Advisors LLC | 11,200 | $48.5K |
| TCI Wealth Advisors, Inc. | 295 | $1.28K |
| Signaturefd, LLC | 238 | $1.03K |